GRAS Notices
-
GRN No. 572
Lactase from Bifidobacterium bifidum produced in Bacillus licheniformis
Intended Use: | For use in the dairy industry to catalyze the hydrolysis of lactose in the production of lactose reduced products at levels not to exceed the minimum amount necessary to achieve the intended technical effect. |
---|---|
Basis: | Scientific procedures |
Notifier: | Novozymes North America, Inc. |
Notifier Address: | 77 Perry Chapel Church Road, P.O. Box 576, Franklinton, NC, 27525 |
Date of filing: | Mar 23, 2015 |
GRAS Notice (releasable information): | GRN 572 (in PDF) (1.4 MB) |
Date of closure: | Aug 28, 2015 |
FDA's Letter: | FDA has no questions |
-